Cargando…

Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer’s disease continuum

BACKGROUND: Large-scale neuronal network breakdown underlies memory impairment in Alzheimer’s disease (AD). However, the differential trajectories of the relationships between network organisation and memory across pathology and cognitive stages in AD remain elusive. We determined whether and how th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Kok Pin, Qian, Xing, Ng, Kwun Kei, Ji, Fang, Rosa-Neto, Pedro, Gauthier, Serge, Kandiah, Nagaendran, Zhou, Juan Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477498/ https://www.ncbi.nlm.nih.gov/pubmed/36053063 http://dx.doi.org/10.7554/eLife.77745

Ejemplares similares

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia
por: Ng, Kok Pin, et al.
Publicado: (2019)

Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study
por: Ng, Kok Pin, et al.
Publicado: (2014)

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
por: Ng, Kok Pin, et al.
Publicado: (2017)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
por: Ng, Kok Pin, et al.
Publicado: (2021)

Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment
por: Gauthier, Serge, et al.
Publicado: (2018)

Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
por: Ba, Maowen, et al.
Publicado: (2016)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Getting Lost Behavior in Patients with Mild Alzheimer’s Disease: A Cognitive and Anatomical Model
por: Yatawara, Chathuri, et al.
Publicado: (2017)

Topology of diffusion changes in corpus callosum in Alzheimer's disease: An exploratory case-control study
por: Kumar, Sumeet, et al.
Publicado: (2022)

Corrigendum: Topology of diffusion changes in corpus callosum in Alzheimer's disease: An exploratory case-control study
por: Kumar, Sumeet, et al.
Publicado: (2023)

In vivo tau staging in Alzheimer’s disease
por: Therriault, Joseph, et al.
Publicado: (2022)

Applications of Alzheimer’s disease staging to clinical trials
por: Therriault, Joseph, et al.
Publicado: (2023)

White matter microstructural abnormalities and default network degeneration are associated with early memory deficit in Alzheimer’s disease continuum
por: Ji, Fang, et al.
Publicado: (2019)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
por: Yatawara, Chathuri, et al.
Publicado: (2021)

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
por: Zhang, Hua, et al.
Publicado: (2018)

Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
por: Zhang, Hua, et al.
Publicado: (2018)

Distinct network topology in Alzheimer’s disease and behavioral variant frontotemporal dementia
por: Ng, Adeline Su Lyn, et al.
Publicado: (2021)

Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional
por: Vipin, Ashwati, et al.
Publicado: (2021)

APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia
por: Vipin, Ashwati, et al.
Publicado: (2023)

Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice
por: Qiu, Lifeng, et al.
Publicado: (2016)

Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention
por: Oh, Sher Li, et al.
Publicado: (2022)

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
por: Macedo, Arthur C., et al.
Publicado: (2023)

Frontotemporal Dementia in Southeast Asia: A Comparative Study
por: Tan, Yee-Leng, et al.
Publicado: (2013)

Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease
por: Fernández Arias, Jaime, et al.
Publicado: (2023)

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly
por: Li, Xiaofeng, et al.
Publicado: (2017)

A novel language-neutral Visual Cognitive Assessment Test (VCAT): validation in four Southeast Asian countries
por: Lim, Levinia, et al.
Publicado: (2018)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Memory markers in the continuum of the Alzheimer’s clinical syndrome
por: Parra, Mario A., et al.
Publicado: (2022)

Frontotemporal dementia and COVID‐19: Hypothesis generation and roadmap for future research
por: Ng, Kok Pin, et al.
Publicado: (2021)

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
por: Gobom, Johan, et al.
Publicado: (2022)

BACE2: A Promising Neuroprotective Candidate for Alzheimer’s Disease
por: Yeap, Yee Jie, et al.
Publicado: (2023)

Light-Induced Pupillary Responses in Alzheimer's Disease
por: Chougule, Pratik S., et al.
Publicado: (2019)

The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on “At-Risk” Individuals
por: Duquenne, Laurence, et al.
Publicado: (2020)

Prevention strategies for Alzheimer’s disease
por: Gauthier, Serge, et al.
Publicado: (2012)

DTI Profiles for Rapid Description of Cohorts at the Clinical-Research Interface
por: Lock, Christine, et al.
Publicado: (2019)

Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer’s Disease and Frontotemporal Dementia
por: Tan, Yi Jayne, et al.
Publicado: (2021)

Serial position effects differ between Alzheimer’s and vascular features in mild cognitive impairment
por: Chander, Russell Jude, et al.
Publicado: (2018)

Voluntary cognitive screening: characteristics of participants in an Asian setting
por: Ho, Vanda, et al.
Publicado: (2015)

Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer’s continuum
por: Kuhn, Elizabeth, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_96l6bcqrgem1rtg958p159jk9j